Welcome to our dedicated page for Cameco SEC filings (Ticker: CCJ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating uranium reserve data, production cost shifts, or executive stock sales in Cameco’s dense disclosures can feel like mining ore yourself. Each new Cameco annual report 10-K simplified still runs hundreds of pages, while a single 8-K can move the uranium market overnight. Stock Titan resolves this challenge by pairing real-time EDGAR feeds with AI that translates technical jargon into clear insight, so Cameco SEC filings explained simply becomes reality.
Our platform auto-tags every document the moment it hits EDGAR—whether it’s a Cameco quarterly earnings report 10-Q filing, a sudden operations update with Cameco 8-K material events explained, or the latest Cameco proxy statement executive compensation table. Interactive summaries highlight where management revises production guidance, discloses long-term sales contracts, or details environmental obligations. Meanwhile, Cameco Form 4 insider transactions real-time alerts surface buying and selling patterns, giving you immediate context around Cameco insider trading Form 4 transactions and broader Cameco executive stock transactions Form 4.
Use cases include:
- Comparing segment margins quarter-over-quarter with AI-curated benchmarks
- Flagging mine shutdowns or supply pacts the instant they appear in 8-Ks
- Evaluating CEO incentives by linking proxy data to performance metrics
Whether you’re modeling uranium prices or monitoring governance risk, understanding Cameco SEC documents with AI means less time scrolling and more time deciding. Dive into Cameco earnings report filing analysis, track every note, and act the moment critical information surfaces—without wading through geological appendices first.
Cameco Corporation shareholder plans NYSE sale after option exercise
A shareholder of Cameco Corporation has filed notice of a planned sale of 50,000 common shares through broker Solium Financial Inc. on the NYSE, with an approximate sale date of 12/19/2025. The filing lists an aggregate market value of $4,499,500.00 for the shares to be sold. These shares were acquired on 12/19/2025 via a stock option exercise from Cameco Corporation, paid in cash for 50,000 shares. The filing notes that 435,407,158 common shares were outstanding, providing context for the size of the planned sale.
Cameco Corporation (CCJ) filed a Form 144 disclosing a proposed sale of 19,460 common shares with an aggregate market value of $1,680,000. The filing shows the shares represent part of the issuer's outstanding common stock of 435,387,448 shares and names the intended sale date as 09/15/2025 on the NYSE. The shares were acquired on 09/15/2025 through a stock option exercise from Cameco Corporation and payment was in cash. The filer reports no securities sold during the past three months and includes the standard attestation that the seller is not aware of undisclosed material adverse information.
Cameco Corporation (CCJ) notice: an individual intends to sell 500 common shares on the NYSE through Solium Financial on 09/10/2025 for an aggregate market value of $39,735. The shares were acquired from long‑term incentive vesting in 2018–2019 (129, 184, and 187 shares on specific vesting dates) with cash payment at acquisition. The filer reports no securities sold in the past three months and affirms they are not aware of any undisclosed material adverse information about the issuer. This form is a Rule 144 notice of proposed sale and documents the planned transaction and acquisition history.
Cameco Corporation (CCJ) submitted a Form 144 reporting a proposed sale of 500 common shares with an aggregate market value of 36,170.00, to be sold approximately on 06/24/2025 on the NYSE through BMO Investorline.
The filing shows those shares were acquired by open-market purchases on 11/04/2014 (400 shares) and 11/06/2014 (100 shares), paid in cash. It lists total shares outstanding of 435,387,448 and records a sale of 500 shares on 06/23/2025 with gross proceeds of 34,860.00. The seller certifies they are unaware of any undisclosed material adverse information.
Cameco Corporation (CCJ) filed a Form 144 notifying a proposed sale of 500 common shares. The filing lists the broker as BMO Investorline (100 King St W, Toronto) and shows an aggregate market value of $34,860 for the shares to be sold on the NYSE with an approximate sale date of 06/23/2025. The company’s shares outstanding are reported as 435,387,448.
The securities were acquired on 11/04/2014 in an open-market purchase with payment in cash. The filing reports "Nothing to Report" for securities sold during the past three months. The supplied content does not include the filer CIK or the name of the person for whose account the securities are to be sold.
FAQ
What is the current stock price of Cameco (CCJ)?
What is the market cap of Cameco (CCJ)?
